| Autor: |
Leddin D; Division of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada., Singh H; Section of Gastroenterology, Deparment of Internal Medicine, University of Manitoba, Winnipeg, MB R3E 3P4, Canada., Armstrong D; Division of Gastroenterology, McMaster University, Hamilton, ON L8S 4K1, Canada., Cheyne K; Canadian Digestive Health Foundation, Oakville, ON L6M 4J2, Canada., Galts C; Division of Gastroenterology, McMaster University, Hamilton, ON L8S 4K1, Canada., Igoe J; Division of Digestive Care & Endoscopy, Department of Medicine, Dalhousie University, Halifax, NS B3H 4R2, Canada., Leontiadis G; Division of Gastroenterology, McMaster University, Hamilton, ON L8S 4K1, Canada., McGrath J; Department of Medicine, Memorial University, St. John's, NL A1B 3V6, Canada., Pray C; Division of Gastroenterology, McMaster University, Hamilton, ON L8S 4K1, Canada., Sadowski D; Department of Medicine, University of Alberta, Edmonton, AB T6G 2G3, Canada., Shahidi N; Division of Gastroenterology, Department of Medicine, University of British Columbia, Vancouver, BC V5Z 1M9, Canada., Sinclair P; INSINC Consulting Inc., Guelph, ON N1G 3G3, Canada., Tse F; Division of Gastroenterology, McMaster University, Hamilton, ON L8S 4K1, Canada., Yanofsky R; Division of Gastroenterology, University of Toronto, Toronto, ON M5S 1A1, Canada. |
| Abstrakt: |
Competing Interests: D.A. has received grants from Nestle Health Sciences and the Weston Family Foundation, Consulting fees from the Canadian Partnership Against Cancer (CPAC) and The Scripps Research Institute, honoraria from Viatris, Takeda and Fresenius Kabi, payment for expert testimony from McCarthy Tetrault and Dives, Harper, Stanger & Mizrahi, support for attending meetings from the CPAC European Commission on Colorectal Cancer and International Working Group for the Classification of Oesophagitis (IWGCO), holds patents from A.I. VAL:I Inc., advisory board participation with Sanofi (honorarium), Cinclus Pharma (no payment), Phathom Pharma (no payment), and Takeda Canada (honorarium), leadership roles with Canadian Digestive Health Foundation, IWGCO and A.I. VALI Inc. K.C. is paid as the Executive Director of the Canadian Digestive Health Foundation. J.M. has received honoraria for lectures by Abbvie, support for attending meettings from Abbvie, for participation on advisory boards for Abbvie, BioJamp, Pfizer, and Cellitron, and is the VP Administrative Affairs for the Canadian Association of Gastroenterology. P.S. is paid consulting fees as Managing Editor for the Journal of the Canadian Association of Gastroenterology. H.S. has received consulting fees from Pendopharm Canada, Ferring Canada, Amgen Canada, Sandoz Canada, Takeda Canada, Bristol-Myers Squibb Canada, Guardant Health, and Abbvie Canada. N.S. has received honoraria for lectures from Pharmascience and Boston Scientific. Nothing to disclose for all other authors. |
